The SPRINT trial study was an important leap towards tighter blood pressure control in patients who had a history of cardiovascular disease and were at high risk of recurrent event but with no history of stroke or diabetes.
Guidelines update based on SPRINT trial
The 2017 ACC/AHA update on hypertension recommended:
For patients with Stable coronary artery disease – Treat to BP goal <130/80 mm Hg (COR I, LOE B-R for SBP and C-EO for DBP)
Use antihypertensive medications if prior clinical CVD or 10-year ASCVD risk score is ≥10% and BP is ≥130/≥80 mm Hg (COR I, LOE A for SBP and C-EO for DBP)